Johannes Schmoellerl

Cancer Biology & Functional Cancer Genomics – Postdoc @IMPvienna

[Johannes Schmoellerl @JoeySc1]

I am thrilled to announce that I have received a “Disruptive Innovation Grant” that will enable us to study leukemia relapse and to systematically explore new molecular countermeasures. Extremely grateful to @oeaw and @FWF_at for this opportunity!

[IMP @IMPvienna]

Congrats, Johannes Schmoellerl (@JoeySc1, postdoc with @johannes_zuber), on a "Disruptive Innovation Grant" for research on Acute Myeloid Leukaemia (#AML).
👉🏽https://t.co/dPioDmLVji
@oeaw @FWFOpenAccess

[Johannes Schmoellerl @JoeySc1]

@HannahUckelmann Congratulations! 🎉

[Johannes Schmoellerl @JoeySc1]

Very proud!! 🥳 Romana (@r_maerschalk), our amazing master’s student, presented her work at the annual meeting of the Austrian Society of Hematology & Oncology and won a Young Investigator Award! Congratulations!!! 🎉

[European Hematology Association @EHA_Hematology]

#EHA would like to congratulate this year's #TRTH scholars on completing the spring course.

We would also like to thank our faculty for providing their insights throughout the course.

See more about #TRTH here: https://t.co/RLlqoVeZuO

[European Hematology Association @EHA_Hematology]

The #TRTH spring course is off to a great start with team building exercises and sessions on how to get published, writing & reviewing science, and more.

Interested in joining the next cohort? The call for TRTH 2025 opens on March 22. Learn more here: https://t.co/RLlqoVeZuO

[IMP @IMPvienna]

Johannes Schmoellerl (@JoeySc1), postdoc with @johannes_zuber, received the Wilhelm Türk Prize from the Austrian Soc. of Haematology & Medical Oncology and a grant from Fellinger Cancer Research Fund for his research on #AML 🥳⤵️
https://t.co/yGAOyLNpgt

[Shai Izraeli @ShaiIzraeli]

Very excited to share our new paper just published in Nature Communications https://t.co/P5kwalTEMU. This research lead by Eitan Kugler and Shreyas Madiwale , identified how to treat ERG-driven leukemias.

[Johannes Schmoellerl @JoeySc1]

Check out our new paper! Together with @JessicaEbner92, colleagues of the @florian_grebien lab and our collaborators, we show that loss of the ABC-transporter ABCC1 or interfering with glutathione metabolism sensitizes leukemia cells to Venetoclax therapy. #leukemia research 👇

[Feng Zhang @zhangf]

Since the discovery of CRISPR-Cas systems, people have wondered if a similar type of system exists in eukaryotes. Today, we report in @Nature the characterization of Fanzor, a eukaryotic RNA-guided system that can be reprogrammed for human genome editing. https://t.co/aKLMMEBRkk

[ITCC @ITCC_eu]

That's a wrap!

The last two days have been incredibly productive and filled with great discussions.

Special thanks to @StAnna_CCRI, St. Anna Children’s Hospital and @MedUni_Wien for hosting us in Vienna☀️

Thank you all for joining us - We look forward to the next edition!

[Johannes Schmoellerl @JoeySc1]

Very cool to see our study in collaboration with @PharmaVetmeduni finally published in @BloodJournal! Check out the summary! 👇🏽

[Institute of Pharmacology and Toxicology @PharmaVetmeduni]

Just out in @BloodJournal: Super excited to share our findings that identify Strawberry Notch Homolog 2 (SBNO2) as a critical mediator for STAT3-driven hematopoietic malignancies by modeling STAT3 mutations and functional genetic screens. 1/
Full paper: https://t.co/q9yHvEnz4T

[Florian Grebien @florian_grebien]

📢👩‍🎓👨‍🎓The #grebienlab is hiring again! We look for 1 #postdoc and 1 #PhD #student to help us unravel molecular mechanisms of #fusion #oncoproteins in #cancer through functional genomics, imaging and biochemistry. 🧬🧫💊💻 @VetmeduniVienna Please RT!
👉 https://t.co/PQf4Ike8eB

[Johannes Schmoellerl @JoeySc1]

Very excited to share our newest publication out in @BloodJournal! Check out the summary below! 👇🏽

[Bardelli Lab @BardelliLab]

Almost 80 years ago, Luria and Delbrück measured mutation rate in bacteria. Today, in collaboration with @IFOMresearch Lagomarsino we adapted their assay to measure mutation rates before and under treatment in cancer cells. Find out more on @NatureGenet https://t.co/KLGkB8Yq3f

[Lydia Finley @lydfinley]

Pretty wild: cancer cells more likely to spread during sleep (!) https://t.co/r1JYK4Pzge Interesting and dramatic example of how physiology intersects with fundamental cell biology-- here, circadian hormone rhythms and intravasation

[Johannes Schmoellerl @JoeySc1]

@emiliocasanova9 @Stadt_Wien @SonjaSucic Congratulations!

[Florian Grebien @florian_grebien]

📢Join the #grebienlab @VetmeduniVienna! We are looking for a #postdoc to work on #genetic determinants of #drug response and resistance in #leukemia. #CRISPR screening➕mouse models➕patient cells➕large datasets➡️new #mechanisms➕#biomarkers. RT/DM! 👉https://t.co/NpfuGTv0OP

[Johannes Schmoellerl @JoeySc1]

@HeidiA_Neubauer @FWF_at @VetmeduniVienna Congratulations!

[IRB Barcelona @IRBBarcelona]

🔬Palmitic acid promotes #cancer #metastasis and leaves a more aggressive “memory” in tumour cells.

👉A study led by #IRBBarcelona & @icreacommunity researcher Dr. @SalvadorAznar3 (@AznarLab).

📰Published in @Nature

➡️ https://t.co/KODuLwDKWk

#IRBScience

🧵👇

[Florian Grebien @florian_grebien]

We have an opening for a Postdoc to work on #biomolecular #condensates in fusion-protein driven #cancer. Exciting work involving cellular engineering, high-resolution #imaging and #CRISPRi screening. Check 👉 https://t.co/NpfuGTv0OP or DM me! Please RT. @VetmeduniVienna